Effect of Intravenous Haloperidol on the Duration of Delirium and Coma in Critically Ill Patients (Hope-ICU)

Abstract

In critically ill patients the administration of regular haloperidol did not reduce the incidence of delirium or coma.

Level of evidence: 1B (single-centre randomised controlled trial with low risk of bias)